As part of Ascension’s Marketing and Communications thought leadership strategy, several Ascension Advocacy leaders recently wrote columns expressing support for the 340B drug discount program and its positive impact on their communities.
Nancy Anness, Chief Advocacy Officer, Ascension Tennessee, wrote a piece published in The Tennessean; and Brian Massey, Chief Advocacy Officer, Ascension Alabama, published an article in Al.com.
Both leaders highlight the positive impact of the program, applaud lawmakers for their efforts to find solutions to high drug prices, and encourage them to preserve 340B.